Jakartaorders 24 Cases Of COVID-19 Variant Omicron

Illustration-Unsplash

JAKARTA - Head of the Epidemiological Surveillance and Immunization Section of the DKI Jakarta Health Office, Ngabila Salama, revealed that currently there are 24 cases of BN.1 COVID-19 in Jakarta. BN.1 is a derivative of the Omicron variant. Ngabila revealed that the majority of BN.1 cases experienced mild symptoms. Almost all case transmission comes from local transmission and one case of foreign travelers (PPLN). "Of the 24 patients of BN.1 domiciled in Jakarta. As many as 30 percent are asymptomatic, 70 percent are mild. Only one is PPLN, the other is local transmission," Ngabila said in a short message, Friday, December 9. Ngabila explained, all cases of BN.1 carried out treatment at home in self-isolation. Furthermore, Ngabila said that the BN.1 case was first detected in Jakarta since October 10, 2022. "In the last week, the proportion is 5 percent of the total variant found in Jakarta from the results of genome sequencing," said Ngabila. So far, the development of COVID-19 cases in Jakarta and the death rate has decreased over the past two weeks. "The trend of positive cases has decreased in the last 2 weeks. The trend of death, the use of beds in hospitals has decreased in the past week. Conditions are under control," he said. The Ministry of Health reported that the Omicron BN.1 subvariant was first detected in the Riau Islands on September 16. BN.1 cases in Indonesia have so far been reported from DKI Jakarta, Central Java, Riau Islands, North Sumatra, West Kalimantan, and South Kalimantan. "We found a variant that is different from the other. This is what we are monitoring again, whether this will be the cause of the increase in cases or not in Indonesia," said Head of the Communication and Public Service Bureau of the Ministry of Health Siti Nadia Tarmizi. According to Nadia, BN.1 is a sublineage of BA.2.75 which is a derivative of the Omicron variant. In the world, first reported at the end of July 2022 from India. Currently, BN.1 cases are reported in the United States, Britain, Austria, Australia, and India. "The United States Centers for Disease Control and Prevention (CDC) is monitoring this variant, because there has been an increase in cases with the BN.1 variant over the past 1 month," he said. Globally proportions of cases in the past week were 5.1 percent, an increase from 4.4 percent from the previous week.